Radiolabeled fibroblast activation protein inhibitor (FAPI) PET in oncology: has the time come for 18F-fluorodeoxyglucose to think to a well-deserved retirement? Priscilla GuglielmoLuca Guerra Spotlight 30 November 2020 Pages: 1 - 2
Diagnostic role of 11C-methionine PET/CT in patients with multiple myeloma and other plasma cell malignancy: a literature review Daria MaccoraCarmelo CaldarellaMaria Lucia Calcagni Mini-Review 05 January 2021 Pages: 3 - 17
Artificial intelligence techniques support nuclear medicine modalities to improve the diagnosis of Parkinson’s disease and Parkinsonian syndromes Barbara PalumboFrancesco BianconiMario Luca Fravolini Expert Review Open access 14 December 2020 Pages: 19 - 35
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? Margarita KirienkoMatteo BiroliMartina Sollini Expert Review 28 January 2021 Pages: 37 - 55
Change of management by using hybrid imaging with radiolabelled choline in biochemical recurrent prostate cancer: a systematic review and a meta-analysis Matteo FerrariJulien RenardGiorgio Treglia Systematic Review 17 January 2021 Pages: 57 - 71
Head-to-head comparison between 18F-FDG PET/low-dose CT and 18F-FDG PET/contrast-enhanced CT in relapsing ovarian carcinoma: a systematic review and meta-analysis Michela MassolloGiorgio TregliaArnoldo Piccardo Meta-Analysis 05 January 2021 Pages: 73 - 81
PET–CT for staging patients with muscle invasive bladder cancer: is it more than just a fancy tool? Valérie FonteyneK. De ManG. Villeirs Meta-Analysis 04 November 2020 Pages: 83 - 94
Impact of PSMA PET on management of biochemical recurrent prostate cancer: a systematic review and meta-analysis of prospective studies Ao LiuLu ChenDanfeng Xu Meta-Analysis 19 January 2021 Pages: 95 - 108
False iodine-131 MIBG scintigraphy findings in adrenal tumors: correlation with MR imaging Serena Dell’AversanaValeria RomeoSimone Maurea Pictorial Essay Open access 16 December 2020 Pages: 109 - 115